Overview
Denis Logunov is a virology specialist with an H-index of 30 at Gamaleya Research Institute (Member). Has been published in The Lancet, Proceedings of the National Academy of Sciences, The Lancet Regional Health - Europe. Based in Unknown, Unknown, Global.
Biography
Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
LancetFront ImmunolInt J Biol MacromolJ Mol Med (Berl)
Key Publications
COVID-19 vaccination and HIV-1 acquisition.
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activity.
Development of adenoviral vector-based mucosal vaccine against influenza.
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive
Related Specialists
View AllAre you Denis Logunov?
Claim your MDRPedia profile to unlock analytics, manage your digital legacy, and receive your verified badge.